Osaic Holdings
PHIO icon

Osaic Holdings’s Phio Pharmaceuticals PHIO Stock Holding History

Osaic Holdings’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.44K Buy
+2,000
New +$2.28K ﹤0.01% 6981

Other funds holding PHIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Osaic Holdings's PHIO Position: Q1 2026 in Review

Osaic Holdings opened a new position in Phio Pharmaceuticals (PHIO) in Q1 2026: 2,000 shares worth $2.44K. The stake represents ﹤0.01% of the portfolio and ranks #6981 among its holdings.

24 funds tracked by Wall St. Rank hold PHIO as of Q1 2026.

  • Osaic Holdings held 2,000 shares of Phio Pharmaceuticals worth $2.44K as of Q1 2026.
  • Phio Pharmaceuticals was a new Osaic Holdings position in Q1 2026.
  • Phio Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6981 holding.
  • 24 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.